EphA5 gene silenced by methylation has been demonstrated in breast cancer [14], prostate cancer [20], and colorectal cancer [21], implying that the hypermethylation of EphA5 might be of great importance during tumorigenesis and progression in cancer. This evidence concerns the gene EPHA5 and breast cancer.